Tessera Defense and Homeland Security Inc (HLSQ) Stock Ticker
HLSQ right now
Market factors today
Unlock the full HLSQ picture
About Tessera Defense and Homeland Security Inc
Tessera Defense & Homeland Security, Inc. operates as a clinical-stage microbiome company, which engages in the development of both natural and engineered phage cocktails designed to target and destroy harmful bacteria in chronic diseases, such as cystic fibrosis and atopic dermatitis. Its product pipelines include BX004 and BX005, which are treatments for cystic fibrosis and atopic dermatitis respectively. The company was founded in March 2015 and is headquartered in Dover, DE.
HLSQ stock facts
| Ticker symbol | HLSQ |
| Exchange | New York Stock Exchange Arca |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $1.4M |
| CEO | Michael Oster |
| Employees | 20 |
| Headquarters | Dover, DE, US |
| IPO date | 2026-09-11 |
| Website | www.biomx.com |
What you can see for HLSQ on Tickr
Live HLSQ price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the HLSQ report.
Rankings
FAQ
What is the ticker symbol for Tessera Defense and Homeland Security Inc?
The ticker symbol for Tessera Defense and Homeland Security Inc is HLSQ, listed on the New York Stock Exchange Arca.
What is HLSQ?
Tessera Defense & Homeland Security, Inc. operates as a clinical-stage microbiome company, which engages in the development of both natural and engineered phage cocktails designed to target and destroy harmful bacteria in chronic diseases, such as cystic fibrosis and atopic dermatitis. Its product pipelines include BX004 and BX005, which are treatments for cystic fibrosis and atopic dermatitis…